We'll be there! Secure your free place today: buff.ly/fqZyPnO
@parkinsons.org.uk #ParkinsonsUK #ParCon #Parkinsons
@parkinsonseurope.bsky.social
@parkinsonseurope.bsky.socialWe'll be there! Secure your free place today: buff.ly/fqZyPnO
@parkinsons.org.uk #ParkinsonsUK #ParCon #Parkinsons
@scienceofpd.bsky.socialIn GBA- #Parkinsons, subthalamic nucleus-deep brain stimulation treatment at later stages is associated with⬆️risk of cognitive decline. Earlier STN-DBS in GBA-PD may extend the period of improved motor function before onset of cog. decline
movementdisorders.onlinelibrary.wiley.com/doi/10.1002/...
@scienceofpd.bsky.socialAnti-inflammatory agent dapansutrile exerts neuroprotective effects in preclinical models of #Parkinsons
link.springer.com/article/10.1...
@scienceofpd.bsky.socialResearchers present the neuroprotective effects of AZP2006 (a PGRN/PSAP complex stabilizer) in several preclinical #Parkinsons models (in vitro & vivo), counteracting mitochondrial damage & toxicity of alpha-synuclein preformed fibril spreading
journals.plos.org/plosone/arti...
@scienceofpd.bsky.socialThe work provides a framework for future economic evaluations of disease-modifying therapies in #Parkinsons, recommending an individual-level state-transition (microsimulation) approach for the framework implementation
@scienceofpd.bsky.socialA evidence review & expert assessment of 30 published economic evaluations reveals gaps that make it challenging to assess the cost effectiveness of a putative disease modifying therapies for #Parkinsons
link.springer.com/article/10.1...
@worldpdcongress.bsky.social🌎 WPC 2029 Ambassador Applications are NOW OPEN! Join us as a Science or Parkinson Ambassador. Apply by Nov. 5! #WPC2029 #Parkinsons #WorldParkinsonCongress
@asapresearch.parkinsonsroadmap.orgA new GP2 #blog recaps GP2’s Regional Investigator Meeting in Nairobi, sharing research updates from teams advancing #Parkinsons genetics research across the continent and perspectives from six African GP2 trainees.
🔗 Read more: bit.ly/4rN43kY
@worldpdcongress.bsky.social🌎 WPC welcomes five new Board members bringing global expertise, lived experience & fresh perspectives to Parkinson’s advocacy.
Read the full press release here: https://ow.ly/NMNK50ZTrg6
@breakingnews06.bsky.socialSon who used AI to help save mum's life hopes case unlocks clues for other Parkinson's patients #Parkinsons #AIInHealthcare #ClinicalTrials #HealthTech #PatientAdvocacy
@breakingnews06.bsky.socialSon who used AI to help save mum's life hopes case unlocks clues for other Parkinson's patients #Parkinsons #AIInHealthcare #ClinicalTrials #HealthTech
@parkinsonseurope.bsky.socialIf you'd be happy to speak to Parkinson's Life about your experiences, please comment below or email [email protected]
Thank you so much in advance 💚
@scienceofpd.bsky.socialNew review provides an overview of mechanisms of lysosomal dysfunction in neurodegenerative conditions, particularly #Parkinsons, #Alzheimers, frontotemporal dementia & amyotrophic lateral sclerosis #ALS
www.nature.com/articles/s41...
@scienceofpd.bsky.socialThey found that inhibition of enzymes involved in long-chain unsaturated lipid synthesis reduces α-synuclein toxicity. Medium-chain Triglyceride supplementation rescues αSyn-induced motor impairment. They also observed lower plasma TAGs in #Parkinsons cohorts
@scienceofpd.bsky.socialNew research from @NollenLab & collaborators reports that #Parkinsons-associated α-synuclein progressively alters lipid metabolism in aging C. Elegans; α-syn⬇️overall content of triacylglycerols & disrupts the structure of lipid droplets & mitochondria
link.springer.com/article/10.1...
@worldpdcongress.bsky.socialSara Whittingham—United States Air Force Veteran, physician, triathlete, mom, and person living with #Parkinsons — shared her book, Oh Crap! It’s Parkinson’s: A Rebel’s Guide to Taking Back Control of Your Life, at #WPC2026 in Phoenix this past May.
@britishneuro.bsky.socialProfessor Madeleine Lowery from @ucddublin.bsky.social
will open #BNA2027 with her plenary:
“Next Generation #DeepBrainStimulation for #Parkinsons Disease: Modelling, Neural Dynamics and Closed-loop Control”
🤝 Supported by @neuroscienceirl.bsky.social
@asapresearch.parkinsonsroadmap.orgThis month’s Discover ASAP features Nolwazi Gcwensa, MSc, PhD, on SynDOVE, an accessible protocol for studying synaptic proteins in 3D using confocal microscopy. 🔬
The approach can reveal changes that 2D analysis may miss, offering new insights into #Parkinsons.
📺 Watch: bit.ly/4z5OvuP
@longevitytech.bsky.socialLW-1017, an oral drug that switches the brain’s cleanup system back on, reduced Parkinson’s and Alzheimer’s pathology in aged mouse models.
Link as first comment.
@maskblocwr.bsky.social